Blood Purification
Catheter Design for Continuous Flow Peritoneal DialysisRonco C.a · Gloukhoff A.b · Dell’Aquila R.a · Levin N.W.caDepartment of Nephrology, St. Bortolo Hospital, Vicenza, Italy; bMedcomp, Medical Components, Inc., Harleysville, Pa., USA and cRenal Research Institute, New York, N.Y., USA
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Published online: January 17, 2002
Issue release date: 2002
Number of Print Pages: 5
Number of Figures: 6
Number of Tables: 0
ISSN: 0253-5068 (Print)
eISSN: 1421-9735 (Online)
For additional information: https://www.karger.com/BPU
Abstract
A new catheter for continuous flow peritoneal dialysis is presented. One of the main issues in this field is the safety and good clinical tolerance of the catheter. In this case, the size and diameter of the cannula has not been increased in comparison to previous PD catheters. Furthermore, the materials utilized are designed for maximum comfort of the patient and minimal traumatisation of the peritoneal membrane. Nevertheless, the two compartments of the catheter allow for high dialysate flows without creating high resistance and the rate of recirculation is minimal in conditions of simulated continuous flow PD. Furthermore, the characteristic of the new catheter is the presence in the inflow branch of a special diffuser designed like a shower cap that is intended to improve the dialysate inflow distribution in the peritoneal cavity and to increase the contact of the peritoneal membrane with the solution. At the same time, the diffuser prevents a traumatic effect of the inflow dialysate due to high speed infusion or jet flow conditions.
© 2002 S. Karger AG, Basel
Related Articles:
References
-
Twardowski ZJ, Nolph KD, Khanna R, et al: Peritoneal equilibration test. Perit Dial Bull 1987;7:138–147.
- Diaz-Buxo JA, Youngblood BP, Torres AM: Delivered dialysis dose with PD plus therapy: A multicenter study. Am J Nephrol 1998;18:520–524.
-
Durand PY, Freida P, Issad B, Chanliau J: How to reach optimal creatinine clearance in automated peritoneal dialysis. Perit Dial Int 1996;16(suppl 1):S167–S170.
- Twardowski ZJ: Nightly peritoneal dialysis: Why, who, how and when. ASAIO Trans 1990;36:8–16.
- Amici G, Virga G, Da Rin G, Bocci C, Calconi G: Continuous tidal peritoneal dialysis prescription and adequacy targets. Adv Perit Dial 1998;14:64–67.
- Holley JL, Piraino B: Careful patient selection and dialysis prescription are required for effective nightly intermittent peritoneal dialysis. Perit Dial Int 1994;14:155–158.
- Friedlander MA, Rahman M, Tessman MJ, Hanslik TM, Ferrara KA, Newman LN: Variability in calculations of dialysis adequacy in patients using nightly intermittent peritoneal dialysis compared to CAPD. Adv Perit Dial 1995;11:93–96.
-
Durand PY, Slingeneyer A, Benevent D, Chanliau J: CAPD: Peritoneal clearances with a 5th nocturnal automated exchange (Baxter Quantum) (abstract). Perit Dial Int 1997;17(suppl 1):S15.
- Piraino B, Bender F, Bernardini J: A comparison of clearances on tidal peritoneal dialysis and intermittent peritoneal dialysis. Perit Dial Int 1994;14:145–148.
- Steinhauer HB, Keck I, Lubrich-Birkner I, Schollmeyer P: Increased dialysis efficiency in tidal peritoneal dialysis compared to intermittent peritoneal dialysis. Nephron 1991;58:500–501.
- Flanigan MJ, Doyle C, Lim VS, Ullrich G: Tidal peritoneal dialysis: Preliminary experience. Perit Dial Int 1992;12:304–308.
- Brandes JC, Packard WJ, Watters SK, Fritsche C: Optimization of dialysate flow and mass transfer during automated peritoneal dialysis. Am J Kidney Dis 1995;25:603–610.
-
Cruz C, Melendez A, Gotch F, Folden T, Levin NW, Crawford T, Diaz-Buxo JA: Continuous flow peritoneal dialysis: Preliminary clinical experience. Perit Dial Int 2000;20(suppl 1):S6.
- Raj DSC, Self M, Work J: Hybrid dialysis: Recirculation peritoneal dialysis revisited. Am J Kidney Dis 2000;36:58–67.
- Mineshima M, Suzuki S, Sato Y, Ishimori I, Ishida K, Kaneko I, Agishi T: Solute removal characteristics of continuous recirculating peritoneal dialysis in experimental and clinical studies. ASAIO J 2000;46:95–98.
-
Diaz-Buxo JA: Continuous flow peritoneal dialysis. Nephrol News Issues, May 2001.
- Ronco C, Diaz-Buxo JA: Automated peritoneal dialysis, revisitation of the past or beginning of a new PD era? Nephron 2001;87:1–7.
- Gokal R: Peritoneal catheters and exit-site practices toward optimum peritoneal access: 1998 update. Perit Dial Int 1998;18:11–33.
- Diaz-Buxo JA, Cruz C, Gotch FA: Continuous-flow peritoneal dialysis. Blood Purif 2000;18:361–365.
-
Diaz-Buxo JA: Continuous flow peritoneal dialysis – Back to the future? Annual Conference on Dialysis. www.multi-med.com/pdtoday/pdt7/buxo.html.
Article / Publication Details
Published online: January 17, 2002
Issue release date: 2002
Number of Print Pages: 5
Number of Figures: 6
Number of Tables: 0
ISSN: 0253-5068 (Print)
eISSN: 1421-9735 (Online)
For additional information: https://www.karger.com/BPU
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
PubMed ID
